Serum CX3CL1 in PM patients and DM patients, who had an active newly diagnosed form or flaring up of the disease, was markedly increased compared with that in healthy controls (P < 0.01) (Figure 4A). This evidence concerns the gene CX3CL1 and polymyositis.